# CI-994 in Treating Patients With Advanced Myeloma

> **NCT00005624** · PHASE2 · COMPLETED · sponsor: **H. Lee Moffitt Cancer Center and Research Institute** · enrollment: 6 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** CI-994

## Key facts

- **NCT ID:** NCT00005624
- **Lead sponsor:** H. Lee Moffitt Cancer Center and Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-08
- **Primary completion:** 2003-02
- **Final completion:** 2003-02
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2012-09-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005624

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005624, "CI-994 in Treating Patients With Advanced Myeloma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00005624. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*